Application 214860

Type
NDA
Sponsor
ACER THERAPEUTICS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001OLPRUVASODIUM PHENYLBUTYRATESUSPENSION;ORAL2GYesNo
002OLPRUVASODIUM PHENYLBUTYRATESUSPENSION;ORAL3GYesNo
003OLPRUVASODIUM PHENYLBUTYRATESUSPENSION;ORAL4GYesNo
004OLPRUVASODIUM PHENYLBUTYRATESUSPENSION;ORAL5GYesNo
005OLPRUVASODIUM PHENYLBUTYRATESUSPENSION;ORAL6GYesNo
006OLPRUVASODIUM PHENYLBUTYRATESUSPENSION;ORAL6.67GYesNo
007OLPRUVASODIUM PHENYLBUTYRATEFOR SUSPENSION;ORAL0.5GM/PACKETYesNo
008OLPRUVASODIUM PHENYLBUTYRATEFOR SUSPENSION;ORAL1GM/PACKETYesNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
72542-200OLPRUVAsodium phenylbutyrateAcer Therapeutics Inc.NDACurrent
72542-300OLPRUVAsodium phenylbutyrateAcer Therapeutics Inc.NDACurrent
72542-400OLPRUVAsodium phenylbutyrateAcer Therapeutics Inc.NDACurrent
72542-500OLPRUVAsodium phenylbutyrateAcer Therapeutics Inc.NDACurrent
72542-600OLPRUVAsodium phenylbutyrateAcer Therapeutics Inc.NDACurrent
72542-667OLPRUVAsodium phenylbutyrateAcer Therapeutics Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
83756SUPPL 2025-10-15
83729SUPPL 2025-10-14
75602ORIG 2023-09-29
73042ORIG2022-12-27
73027ORIG2022-12-23